Highlights

Simons Trading Research

Author: simonsg   |   Latest post: Wed, 18 May 2022, 11:34 AM

 

Venture Corporation - FY20 Results Preview & Potential Risks for 2021

Author:   |    Publish date:


  • We expect Venture Corp's 2020 earnings to be largely in line with our estimate of S$300m as sequential recovery continues into 4Q20 from further reopening of economies and good demand for customers’ essential products. However, we see three potential key risks for 2021:
    1. delay of new product launches due to weaker market sentiment,
    2. production disruption due to COVID-19 outbreak in Malaysia, and
    3. reduced demand for essential products linked to COVID-19.
  • Maintain BUY on Venture Corp and target price of S$23.76.

Expect 2020 Earnings to be Largely in Line With Our Estimate of S$300m

  • To recap, Venture Corp (SGX:V03)’s 9M20 earnings of S$211m forms around 70% of our full-year forecast. Our 4Q20 earnings forecast of S$89m (+11% q-o-q, -8% y-o-y) is expected to reflect sequential growth but decline on a y-o-y basis.
  • The sequential recovery is expected to be driven by factors which impacted 3Q20 like the further reopening of economies and good demand for customers’ essential products.
  • In addition, several key Venture Corp's customers reported a healthy set of 4Q20 results:
    • Broadcomm’s 4Q20 revenue grew 12% y-o-y;
    • Thermo Fisher’s 4Q20 revenue grew 54% y-o-y; and
    • Illumina’s 4Q20 revenue grew 20% q-o-q, flat y-o-y.

Potential Delay of Product Launches Due to Weaker Market Sentiment

  • Venture Corp’s clients may delay new product launches into the later part of the year if market sentiment weakens. For instance, 4Q20 and 1Q21 saw a resurgence in the number of COVID-19 cases around the world, especially in US and EU, key markets of Venture Corp’s clients.

Risk of Disruption to Production Capacity

  • Although the recently announced two-week movement control order (MCO) for eight states in Malaysia provides flexibility for essential services, such as manufacturing, to continue Venture Corp's employees test positive, it could lead to a temporary disruption to operations or capacity cuts at its factories. Venture Corp’s presence in Malaysia, which includes Johor and Penang (both of which fall within the MCO states), form 81% of its total site area.

Risk of Reduced Demand for Essential Products Linked to COVID-19

  • For 2020, several of Venture Corp’s clients have benefitted from Thermo Fisher, whose full-year revenue grew 26% y-o-y and majority of the growth was driven by COVID-19-related testing equipment.
  • From its 2021 revenue forecast of 9%, Thermo Fisher expects COVID-19-related testing to contribute 2% growth, while the base business contributes the remaining 7%.

Strong Balance Sheet and Good Dividends Provide Limit for Share Price Downside

  • As of end-1H20, Venture Corp recorded US-listed peers which were mostly in net debt positions.
  • More importantly, Venture Corp has consistently paid the same amount of dividends or better than in the preceding year. We expect a dividend of S$0.75 per share this year which translates into an attractive dividend yield of 3.9%.

Venture Corp - Valuation & Recommendation

  • We maintain our earnings forecast for Venture Corp. Maintain BUY with PE-based target price of S$23.76, pegged to +1 standard deviation above its forward mean P/E, of 19.4x on 2021F earnings.
  • At the current Venture Corp share price, the stock offers a dividend yield of 3.9%.

Source: UOB Kay Hian Research - 25 Feb 2021

Share this
Labels: Venture

Related Stocks

Chart Stock Name Last Change Volume 
Venture 17.25 -0.11 (0.63%) 456,800 

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

127  253  193  605 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 Sembcorp Marine 0.106+0.003 
 YZJ Fin Hldg 0.48+0.045 
 Jiutian Chemical 0.11-0.001 
 AA 0.014-0.003 
 HSI 21400MBeC.. 0.056-0.019 
 Dyna-Mac 0.149+0.002 
 Parkson Retail 0.051+0.006 
 HSI 18200MBeP.. 0.062+0.01 
 Tritech 0.037+0.002 
 Genting Sing 0.785-0.005 
PARTNERS & BROKERS